Goldman Sachs Group INC Schedule 13G passive stakes

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.5% of Future Money Acquisition Corporation's ordinary shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.7% of Breeze Acquisition Corp II's ordinary shares as of June 30, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have amended their Schedule 13G filing regarding their beneficial ownership of American Exceptionalism Acquis Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 7.6% of Apex Tech Acquisition Inc.'s ordinary shares as of June 30, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.0% of Tango Therapeutics, Inc. common stock as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 1.7% of EVO GBL Acquisition Corp II's Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 6.1% of Lionheart Holdings' Class A Ordinary Shares.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed a Schedule 13G, disclosing beneficial ownership of Hain Celestial Group, Inc. common stock.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting 0.0% beneficial ownership of Four Leaf Acquisition Corporation's Class A common stock as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 0.6% of Soren Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Origin Materials, Inc. common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 3.8% of Launch Two Acquisition Corp.'s Class A Ordinary Shares as of June 30, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting their beneficial ownership of Himalaya Shipping Ltd. common shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.5% of Dave & Buster's Entertainment, Inc. common stock.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have jointly filed a Schedule 13G, reporting beneficial ownership of 5.3% of Collective Mining Ltd.'s common shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 3.7% of White Pearl Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have updated their beneficial ownership filing for Newbury Street II Acquisition Corp.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting a de minimis beneficial ownership of H&E Equipment Services, Inc. common stock.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting zero beneficial ownership of Class A Ordinary Shares of Fortress Value Acquisition Corp. V.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.7% of Esperion Therapeutics, Inc. common stock as of June 30, 2026.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Chart Industries, Inc. common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 3.5% of Bold Eagle Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 6.4% of Mountain Crest Acquisition 6's ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 7.2% of GalaxyEdge Acquisition Corporation's ordinary shares as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.1% of Newbridge Acquisition Limited's Class A Ordinary Shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 1,056,879 Class A ordinary shares, representing 7.2% of the outstanding shares in Translational Development Acquisition Corp.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.8% of Wolfspeed, Inc. common stock as of June 30, 2026.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting their beneficial ownership of W&T Offshore Inc. common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 7.6% of Sweetgreen, Inc.'s Class A Common Stock as of June 30, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed a Schedule 13G, disclosing beneficial ownership of 5.7% of Netstreit Corp.'s common stock.